This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Nicole Doria-Rose, PhD
Chief, Humoral Immunology Core at Vaccine Researchy Center


Dr. Nicole Doria-Rose is an expert in identification and characterization of broadly neutralizing antibodies from HIV-infected patients, with an emphasis on patients followed from the time of infection. She discovered and developed a high-throughput method for culturing and screening single B cells for antibody discovery, and isolated the most potently HIV-neutralizing antibody yet known. As Chief of the Humoral Immunology Core at the Vaccine Research Center, National Institutes of Health, USA, she leads a program that evaluates the immune responses to novel HIV and COVID-19 immunogens, and investigates the clinical use of broadly neutralizing antibodies for prevention of HIV-1.

Agenda Sessions

  • Broadly Neutralizing Antibodies for HIV Prevention